Title |
Extracellular secretion of a recombinant therapeutic peptide by Bacillus halodurans utilizing a modified flagellin type III secretion system
|
---|---|
Published in |
Microbial Cell Factories, August 2011
|
DOI | 10.1186/1475-2859-10-62 |
Pubmed ID | |
Authors |
Eldie Berger, Michael C Crampton, Nolwandle P Nxumalo, Maureen E Louw |
Abstract |
Through modification of the flagellin type III secretion pathway of Bacillus halodurans heterologous peptides could be secreted into the medium as flagellin fusion monomers. The stability of the secreted monomers was significantly enhanced through gene-targeted inactivation of host cell extracellular proteases. In evaluating the biotechnological potential of this extracellular secretion system an anti-viral therapeutic peptide, Enfuvirtide, was chosen. Currently, Enfuvirtide is synthesised utilizing 106 chemical steps. We used Enfuvirtide as a model system in an effort to develop a more cost-effective biological process for therapeutic peptide production. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Mexico | 1 | 2% |
United States | 1 | 2% |
Germany | 1 | 2% |
Unknown | 45 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 24% |
Student > Bachelor | 10 | 20% |
Student > Ph. D. Student | 7 | 14% |
Student > Master | 5 | 10% |
Student > Postgraduate | 4 | 8% |
Other | 6 | 12% |
Unknown | 5 | 10% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 23 | 47% |
Biochemistry, Genetics and Molecular Biology | 11 | 22% |
Engineering | 3 | 6% |
Environmental Science | 2 | 4% |
Chemistry | 2 | 4% |
Other | 2 | 4% |
Unknown | 6 | 12% |